©The Author(s) 2026.
World J Gastrointest Pharmacol Ther. Mar 5, 2026; 17(1): 112872
Published online Mar 5, 2026. doi: 10.4292/wjgpt.v17.i1.112872
Published online Mar 5, 2026. doi: 10.4292/wjgpt.v17.i1.112872
Table 5 Predictors of post-endoscopic retrograde cholangiopancreatography pancreatitis following fully covered self-expanding metal stent placement (n = 319)
| Variable | Odds ratio | 95% confidence interval | P value |
| Age < 50 years | 0.49 | 0.07-1.92 | 0.369 |
| Female sex | 0.67 | 0.27-1.61 | 0.368 |
| Benign indication | 1.30 | 0.50-3.52 | 0.593 |
| Intact papilla | 0.35 | 0.09-1.43 | 0.143 |
| Precut sphincterotomy1 | 6.48 | 1.17-30.32 | 0.021 |
| Biliary sphincterotomy | 1.19 | 0.31-4.41 | 0.795 |
| Sphincteroplasty1 | 3.70 | 0.99-12.59 | 0.041 |
| Rectal indomethacin | 1.07 | 0.34-2.93 | 0.904 |
| Pancreatic duct stent | 2.33 | 0.58-7.71 | 0.190 |
- Citation: Zhang LY, Tikhe D, Shrigiriwar A, Ermerak G, Lee HH, Sin L, Turner I, Edwards P, Abi-Hanna D, Hourigan L, Kostalas S, Bassan M. Fully covered metal biliary stents confer a higher risk of post-endoscopic retrograde cholangiopancreatography pancreatitis. World J Gastrointest Pharmacol Ther 2026; 17(1): 112872
- URL: https://www.wjgnet.com/2150-5349/full/v17/i1/112872.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v17.i1.112872